Scope of the Study
Alfacalcidol is an active metabolite of Vitamin D, that performs essential functions in regulation of the calcium balance as well as the bone metabolism. It is the Vitamin D-hormone analog that is activated by the enzyme 25-hydroxylase in the liver and osteoblasts for systemic and local D-hormone actions respectively. Moreover, Alfacalcidol is superior to plain vitamin D as the final kidney activation of the latter is regulated by a negative feedback mechanism. It is most commonly prescribed for patients with end stage renal disease.
The market study is being classified, by Application (Pharmaceutical, Veterinary industry and Others) and major geographies with country level break-up.
BOC Sciences (United States), Hydragon Pharma Ltd (China), Henan Tianfu Chemical Co., Ltd. (China), LGM Pharma (United States), Chemaphor Chemical Services (Canada), CARBOGEN AMCIS B.V. (Switzerland), Henan DaKen Chemical CO.,LTD. (China), Schwitz Biotech (India), Toronto Research Chemicals (Canada) and Hubei XinRunde Chemical Co., Ltd. (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Capot Chemical Co.,Ltd. (China), AdooQ BioScience, LLC (United States), Csc Pharmaceuticals International (United States), Pure Chemistry Scientific Inc. (United States) and Mainchem Co., Ltd. (China).
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that China Players will contribute to the maximum growth of Global Alfacalcidol market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Alfacalcidol market by Type, Application and Region.
On the basis of geography, the market of Alfacalcidol has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Usage of Alfacalcidol is Fuelling the Market Growth
- Rising Geriatric Population
- Availability of Alternative Products
- Increasing Prevalence of Renal Disease
- Increasing Investments by Governments
- Presence of Major Players is Leading to Market Growth
Key Target AudienceManufacturers, Raw material suppliers, Government associations, Research organisations and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase